Lilly backs $50M launch of public/private biotech research institute

John Carroll Eli Lilly and Roche Diagnostics have joined an industry consortium that will help launch a new research institute in Indiana that plans to hire a staff of about 100 investigators ...

Continuing its manufacturing revamp, Pfizer unloads another Tennessee plant

Tracy Staton UPM's top leadership is familiar with the Bristol, TN, facility; CEO John Gregory started King Pharma back in 1994. FiercePharma News

A Jilted Shire Exec, Age Discrimination And A Federal Probe?

esilverman Was the head of regenerative medicine at Shire Pharmaceuticals fooled into accepting a promotion? Jeff Jones claims in a lawsuit that the biotech failed to disclose ...

San Diego biotech files $23M IPO for gastroparesis PhIII

John Carroll San Diego-based Evoke Pharma has joined the IPO queue, filing to raise $ 23 million to back a late-stage study of its nasal-spray formulation of metoclopramide ...

GlaxoSmithKline nabs key FDA approvals for two melanoma drugs

Tracy Staton Two of GlaxoSmithKline's hopes for 2013 are now fulfilled: The company won FDA approval for its melanoma treatments Tafinlar and Mekinist, both targeted at patients ...

The AbbVie Culture Change Continues: 100 Scientists Will Be Laid Off

esilverman Less than a month after AbbVie quietly disclosed that its chief scientific officer is unexpectedly retiring (see this), the drugmaker is now shaking up R&D and ...

ASCO presentations portend future shock of immunotherapy drug prices

John Carroll This weekend a slate of biopharma companies will be presenting new data at ASCO underscoring the big new role that immunotherapy drugs will be playing in the fight against ...

Sacre Bleu! European Agency Rebuffs French Regulator Over Bayer Acne Pill

esilverman Now what will French authorities do? After months of debate, the European agency that coordinates regulation of medicines on the continent has decided that the controversial ...

Elan execs ready fallback plan as Royalty attacks ‘jumble’ of deals

John Carroll The sparring between Elan and Royalty Pharma over a sweetened buyout bid is going into late rounds, with Royalty swinging away at Elan's recent string of deals in an ...

FDA Accepts sNDA for Higher Concentration Dose of Copaxone

barbara.lempert Teva Announces FDA Acceptance of sNDA for a Higher Concentration Dose of COPAXONE® Given Three Times a Week   JERUSALEM–(BUSINESS WIRE)–May. 30, 2013– ...

Chiltern Promotes Alecia Barbee To VP, Global Biometrics

mia.burns Chiltern Announces The Promotion Of Alecia Barbee To VP, Global Biometrics LONDON and WILMINGTON, N.C., May 30, 2013 /PRNewswire/ — Chiltern International Limited ...

Report: OnlineDoctor Review Sites Significantly Influence Consumers

barbara.lempert New Report Shows OnlineDoctor Review Sites Significantly Influence Consumers Perceptions About Their Doctors Vitals grows as more consumers seek multiple indicators ...
© 2018 Global Regulatory Science. All rights reserved. Site Admin · Entries RSS · Comments RSS